开元官网登录入口

Recently, with the support of MicroPort® Group's overseas sales team and channel resources, Shanghai MicroPort MedBot (Group) Co., Ltd. (referred to as "MicroPort® MedBot®") has completed overseas contracts. With its advanced technological innovation, stable product performance, and comprehensive training services, the Toumai® four-arm laparoscopic surgical robot (referred to as "Toumai® ") has gained favor among customers. It has achieved the first overseas sales order for a Chinese developed laparoscopic surgical robot, making a breakthrough in the international market for high-end medical equipment in the field of Chinese developed laparoscopic surgical robot.

The entry of the Toumai® into the international market marks the official implementation of Toumai®'s global strategy and is a key milestone in the globalization of the Chinese developed laparoscopic surgical robot industry. As the shaper and leader of the Chinese developed laparoscopic surgical robot industry, MicroPort® MedBot® Group has always aimed to benefit patients with leading medical technology and excellent medical products. They continue to build the "Chinese-developed” high-end surgical robot brand, providing more high-quality and inclusive medical robot solutions for global patients and doctors, and are committed to achieving the belief of "Make surgery easier, safer and less invasive"!